Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide. | ChemMedChem;4(4): 582-7, 2009 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide.

Bay, S; Fort, S; Birikaki, L; Ganneau, C; Samain, E; Coïc, Y-M; Bonhomme, F; Dériaud, E; Leclerc, C; Lo-Man, R.

Affiliation

Bay S; Institut Pasteur, Unité de Chimie des Biomolécules, URA CNRS, Paris, France. sylvie.bay@pasteur.fr

ChemMedChem ; 4(4): 582-7, 2009 Apr.

Article in En | MEDLINE | ID: mdl-19226501

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M2) Ganglioside / Melanoma / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: ChemMedChem Journal subject: FARMACOLOGIA / QUIMICA Year: 2009 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M2) Ganglioside / Melanoma / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: ChemMedChem Journal subject: FARMACOLOGIA / QUIMICA Year: 2009 Document type: Article Affiliation country: Country of publication: